Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes-Reference-Cited by-同舟云学术

Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes

Published:2019-02-12 Issue:4 Volume:36 Page:505-513
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Matthews D. R.¹²^ORCID,Paldánius P. M.³,Proot P.³,Foley J. E.⁴,Stumvoll M.⁵,Del Prato S.⁶

Affiliation:

1. Oxford Centre for Diabetes Endocrinology and MetabolismOxford UK

2. Harris Manchester College Oxford UK

3. Novartis Pharma AG Basel Switzerland

4. Novartis Pharmaceuticals Corporation East Hanover NJ USA

5. Divisions of Endocrinology and Diabetes University Hospital Leipzig Germany

6. Department of Clinical and Experimental Medicine Section of Metabolic Diseases and Diabetes University of Pisa Pisa Italy

Funder

Novartis Pharma AG

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.13886

Reference19 articles.

1. Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?

2. Clinical Inertia in People With Type 2 Diabetes

3. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

4. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus

5. Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard‐of‐care metformin monotherapy—the VERIFY trial: a randomized double‐blind trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The societal impact of early intensified treatment in patients with type 2 diabetes mellitus;Journal of Comparative Effectiveness Research;2022-11

2. New trends in the approach to the treatment of type 2 diabetes - observations and benefits in the outpatient practice of a diabetologist;Klinická farmakologie a farmacie;2022-01-04

3. Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2021-11-30

4. Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-06

5. Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy;Meditsinskiy sovet = Medical Council;2021-01-17